An aspirin a day can slash the risk of liver cancer by nearly half, research claims.
People who take a regular low dose are 43% less likely to develop the disease.
The ‘wonderdrug’ also slashes death rates from any liver illness by more than a quarter, the study by US and Swedish scientists suggests.
And it could help fight an epidemic of fatty liver disease fuelled by the obesity crisis.
The research tracked 50,000 Swedes with chronic viral hepatitis, the most common risk factor for liver cancer, for an average of eight years.
It found those who took a low dose, 163mg, for five years cut their chances of liver cancer by 43%.
This fell to 10% in those who only took it for one to three years.
Liver related deaths amounted to 11% of aspirin users compared to 18% of non-users.
Study author Professor Jonas Ludvigsson, of the Karolinska Institute, Stockholm, said the figures link aspirin “with a significantly reduced long-term risk of liver cancer”.
But the NHS and the British Heart Foundation warn only those with cardiovascular disease should take aspirin due to the risk of stomach bleeds.
Source: Read Full Article